Evidence map›Paper›PMID 34524840›Full record

ArticleScience advances2021

Biological resurfacing in a canine model of hip osteoarthritis.

Bradley T Estes, Masataka Enomoto, Franklin T Moutos, Megan A Carson, Jeffrey M Toth, Peter Eggert, Jonathan Stallrich, Vincent P Willard, Deborah J Veis, Dianne Little and 2 more

Abstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Functional tissue engineering of articular cartilage for biological joint resurfacing-The 2021 Elizabeth Winston Lanier Kappa Delta Award.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bradley T EstesCytex Therapeutics Inc., Durham, NC, USA.ORCID 0000-0003-0325-3989
Masataka EnomotoTranslational Research in Pain Program, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA.ORCID 0000-0003-2516-635X
Franklin T MoutosCytex Therapeutics Inc., Durham, NC, USA.
Megan A CarsonDepartment of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA.
Jeffrey M TothMedical College of Wisconsin, Milwaukee, WI, USA.ORCID 0000-0003-3000-7230
Peter EggertMedical College of Wisconsin, Milwaukee, WI, USA.
Jonathan StallrichDepartment of Statistics, North Carolina State University, Raleigh, NC, USA.
Vincent P WillardCytex Therapeutics Inc., Durham, NC, USA.
Deborah J VeisDivision of Bone and Mineral Diseases, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.ORCID 0000-0001-7101-5582
Dianne LittleDepartment of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN, USA.ORCID 0000-0002-1869-7083
Farshid GuilakCytex Therapeutics Inc., Durham, NC, USA.ORCID 0000-0001-7380-0330
B Duncan X LascellesTranslational Research in Pain Program, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA.ORCID 0000-0002-2950-9009

Funding

VISCOELASTIC PROPERTIES OF NORMAL AND OA CHONDRONSR01AG015768 · NIA · WASHINGTON UNIVERSITY · PI GUILAK, FARSHID · 1998 to 2022
$7.7M
Washington University Rheumatic DiseasesResearch Resource-based CenterP30AR073752 · NIAMS · WASHINGTON UNIVERSITY · PI Megan Anne Cooper · 2018 to 2026
$7.6M
Resource Based Center for Musculoskeletal Biology and Medicine (Overall Application)P30AR074992 · NIAMS · WASHINGTON UNIVERSITY · PI MATTHEW J SILVA · 2019 to 2026
$6.8M
OBESITY, BIOMECHANICS, AND INFLAMMATION IN OSTEOARTHRITISR01AG046927 · NIA · WASHINGTON UNIVERSITY · PI GUILAK, FARSHID · 2013 to 2023
$3.2M
Functional Tissue Engineering for Cartilage RepairR42AR055042 · NIAMS · CYTEX THERAPEUTICS INC. · PI GUILAK, FARSHID · 2013 to 2014
$1.3M
Functional Tissue Engineering for Cartilage RepairR41AR055042 · NIAMS · CYTEX THERAPEUTICS INC. · PI GUILAK, FARSHID · 2009 to 2009
$262k
Piezo channel activation and mechanotransduction in chondrocytes during traumatic injuryF32AR074240 · NIAMS · WASHINGTON UNIVERSITY · PI NIMS, ROBERT JOHN · 2018 to 2020
$196k
NIAMS NIH HHS F32 AR074240NIAMS NIH HHS P30 AR073752NIAMS NIH HHS P30 AR074992NIAMS NIH HHS R41 AR055042NIAMS NIH HHS R42 AR055042NIA NIH HHS R01 AG015768NIA NIH HHS R01 AG046927
6 · The paper itself

Abstract

Articular cartilage has unique load-bearing properties but has minimal capacity for intrinsic repair. Here, we used three-dimensional weaving, additive manufacturing, and autologous mesenchymal stem cells to create a tissue-engineered, bicomponent implant to restore hip function in a canine hip osteoarthritis model. This resorbable implant was specifically designed to function mechanically from the time of repair and to biologically integrate with native tissues for long-term restoration. A massive osteochondral lesion was created in the hip of skeletally mature hounds and repaired with the implant or left empty (control). Longitudinal outcome measures over 6 months demonstrated that the implant dogs returned to normal preoperative values of pain and function. Anatomical structure and functional biomechanical properties were also restored in the implanted dogs. Control animals never returned to normal and exhibited structurally deficient repair. This study provides clinically relevant evidence that the bicomponent implant may be a potential therapy for moderate hip osteoarthritis.

Identifiers

PMID34524840
PMCPMC8443182

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.